Vistagen Therapeutics Stock Technical Analysis
| VTGN Stock | USD 4.72 0.11 2.28% |
As of the 25th of April, VistaGen Therapeutics has the Risk Adjusted Performance of 0.0311, coefficient of variation of 2755.47, and Semi Deviation of 3.7. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of VistaGen Therapeutics, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for VistaGen Therapeutics, which can be compared to its competition. Please validate VistaGen Therapeutics jensen alpha and downside variance to decide if VistaGen Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 4.72 per share. Given that VistaGen Therapeutics has jensen alpha of (0.1), we advise you to double-check VistaGen Therapeutics's current market performance to make sure the company can sustain itself at a future point.
VistaGen Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as VistaGen, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VistaGenVistaGen |
VistaGen Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 12.0 | Strong Buy | 4 | Odds |
Most VistaGen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand VistaGen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of VistaGen Therapeutics, talking to its executives and customers, or listening to VistaGen conference calls.
VistaGen Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
VistaGen Therapeutics Technical Analysis
The output start index for this execution was three with a total number of output elements of fifty-eight. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of VistaGen Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
VistaGen Therapeutics Trend Analysis
Use this graph to draw trend lines for VistaGen Therapeutics. You can use it to identify possible trend reversals for VistaGen Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual VistaGen Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.VistaGen Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for VistaGen Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0018 , which may suggest that VistaGen Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.12, which is the sum of squared deviations for the predicted VistaGen Therapeutics price change compared to its average price change.About VistaGen Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of VistaGen Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of VistaGen Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on VistaGen Therapeutics price pattern first instead of the macroeconomic environment surrounding VistaGen Therapeutics. By analyzing VistaGen Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of VistaGen Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to VistaGen Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
VistaGen Therapeutics April 25, 2024 Technical Indicators
Most technical analysis of VistaGen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for VistaGen from various momentum indicators to cycle indicators. When you analyze VistaGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0311 | |||
| Market Risk Adjusted Performance | 0.0607 | |||
| Mean Deviation | 3.0 | |||
| Semi Deviation | 3.7 | |||
| Downside Deviation | 3.84 | |||
| Coefficient Of Variation | 2755.47 | |||
| Standard Deviation | 4.17 | |||
| Variance | 17.39 | |||
| Information Ratio | 0.0134 | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0146 | |||
| Treynor Ratio | 0.0507 | |||
| Maximum Drawdown | 23.45 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 8.23 | |||
| Downside Variance | 14.74 | |||
| Semi Variance | 13.66 | |||
| Expected Short fall | (3.15) | |||
| Skewness | 0.7985 | |||
| Kurtosis | 2.22 |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VistaGen Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in VistaGen Stock, please use our How to Invest in VistaGen Therapeutics guide.Note that the VistaGen Therapeutics information on this page should be used as a complementary analysis to other VistaGen Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for VistaGen Stock analysis
When running VistaGen Therapeutics' price analysis, check to measure VistaGen Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VistaGen Therapeutics is operating at the current time. Most of VistaGen Therapeutics' value examination focuses on studying past and present price action to predict the probability of VistaGen Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VistaGen Therapeutics' price. Additionally, you may evaluate how the addition of VistaGen Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is VistaGen Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VistaGen Therapeutics. If investors know VistaGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VistaGen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Revenue Per Share 0.077 | Quarterly Revenue Growth 1.291 | Return On Assets (0.26) | Return On Equity (0.45) |
The market value of VistaGen Therapeutics is measured differently than its book value, which is the value of VistaGen that is recorded on the company's balance sheet. Investors also form their own opinion of VistaGen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VistaGen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VistaGen Therapeutics' market value can be influenced by many factors that don't directly affect VistaGen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VistaGen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VistaGen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VistaGen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.